selected scholarly activity
-
conferences
- A Novel Substrate for Assessing Thrombin Activity in Whole Blood. Blood. 11279-11280. 2022
- A Population Cohort Study to Evaluate the Risk of Ischemic Stroke Among Individuals with a New Diagnosis of Cancer Compared to Matched Cancer-Free Controls: Impact of Prior Stroke History. Blood. 175-175. 2021
- A Point-of-Care Assay for Measuring Thrombin Activity in Finger-Prick Whole Blood. Thrombosis Research. 4-5. 2019
- Thrombus Stability Explains the Factor V Leiden Paradox: A Mouse Model. Thrombosis Research. 3-4. 2019
- Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant. Blood. 2018
- 12. Abstract Title: Factor V Leiden Mutation Stabilizes Thrombi and Reduces Embolization in Mice. Thrombosis Research. 8-9. 2018
- 9. Abstract Title: Measurement of anti-factor Xa direct oral anticoagulant levels in the plasma samples from the perioperative anticoagulant use for surgery evaluation (PAUSE) study. Thrombosis Research. 7-8. 2018
- Multimerin-1 Binds to Specific Motifs in Vessel Wall Collagens and Contributes to Thrombosis: Novel Insights Regarding the Mechanisms That Support Human and Mouse Platelet Adhesion. Blood. 2017
- PC224 Thrombin-Mediated Human Aortic Endothelial Barrier Dysfunction Alters MicroRNA Pathways Involved in Cell Survival, Injury, and Cancer. Journal of Vascular Surgery. 200S-200S. 2017
- Thrombin-Mediated Human Aortic Endothelial Barrier Dysfunction Alters Microrna Pathways Involved in Cell Survival, Injury, and Cancer. Arteriosclerosis, Thrombosis and Vascular Biology. 2017
- ATTENUATING FIBRINOLYSIS INCREASES THROMBUS STABILITY AND DECREASES PULMONARY EMBOLISM BURDEN. American Journal of Hematology. E371-E371. 2016
- P-SELECTIN-BINDING, PROCOAGULANT MICROPARTICLES DO NOT PREDICT RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH A PREVIOUS UNPROVOKED EVENT. American Journal of Hematology. E379-E379. 2016
- A novel substrate for use in a point of care thrombin generation assay. Journal of Thrombosis and Haemostasis. 211-211. 2015
- Arterial thrombosis is accelerated in histidine-rich glycoprotein deficient mice. Journal of Thrombosis and Haemostasis. 204-205. 2015
- Correlation between deep vein thrombosis and pulmonary embolism using an in vivo mouse model of venous thromboembolism: effect of thrombin inhibition. Journal of Thrombosis and Haemostasis. 77-77. 2015
- Intrinsic and extrinsic coagulation pathways both contribute to ligation-induced deep vein thrombosis in rats. Journal of Thrombosis and Haemostasis. 78-78. 2015
- Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients: Insights From the Co-Ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (Connect AF). Canadian Journal of Cardiology. S275-S276. 2013
- Abnormal megakaryocyte development and platelet function in a mouse model of gray platelet syndrome. Journal of Thrombosis and Haemostasis. 24-25. 2013
- Different effects of antiplatelet vs. anticoagulant agents in mouse bleeding models. Journal of Thrombosis and Haemostasis. 890-890. 2013
- Plasma fibronectin supports hemostasis, controls the diameter of fibrin fibers, and regulates thrombosis. Journal of Thrombosis and Haemostasis. 36-37. 2013
- Kringle domains of plasmin are essential for efficient degradation of fibrin but not fibrinogen. Journal of Thrombosis and Haemostasis. E23-E23. 2012
- Exploring the Impact of Clinical Anticoagulants on Venous Thrombosis Stability Using a Novel Intravital Murine Model. Blood. 558-558. 2011
- A randomized controlled trial comparing aspirin with dalteparin for the prevention of venous thromboembolism following total hip arthroplasty. Journal of Thrombosis and Haemostasis. 303-303. 2011
- BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 and PDE. Journal of Thrombosis and Haemostasis. 49-50. 2011
- Diannexin, a homodimer of annexin A5 (A5), binds phosphatidylserine (PS) with high affinity and is a potent inhibitor of arterial thrombosis in mice. Journal of Thrombosis and Haemostasis. 727-727. 2011
- Investigation of in vitro microparticle clotting activity. Journal of Thrombosis and Haemostasis. 955-955. 2011
- Role of plasma fibronectin in thrombosis and hemostasis: evidence for the fibrin-dependent and independent pathways. Journal of Thrombosis and Haemostasis. 524-524. 2011
- eNOS independent platelet inhibition by atorvastatin. Journal of Thrombosis and Haemostasis. 293-293. 2011
- Plasma Fibronectin In Thrombosis and Hemostasis: Exploring the Fibrin Dependent and Independent Mechanisms. Blood. 215-215. 2010
- Loss of factor IX binding to collagen IV results in abnormal in vivo hemostasis and thrombosis. Journal of Thrombosis and Haemostasis. 70-70. 2009
- The dynamics of platelet activation in vivo. Journal of Thrombosis and Haemostasis. 935-935. 2009
- Monocyte-Derived Microparticles Improve Hemostasis in Factor VIII-Deficient Mice: Exploring the Role of PSGL-1/P-Selectin. Blood. 1161-1162. 2008
- Adiponectin exhibits anti-inflammatory properties in vivo. Canadian Journal of Cardiology. 113C-113C. 2007
- Endothelial anticoagulant heparan sulfate mediates anti-inflammatory effects of antithrombin. The FASEB Journal. A194-A195. 2007
- Atorvastatin Reduced Platelet Accumulation in Arteriolar Thrombi and Increases Platelet S-Nitrosylated N-Ethylmaleimide-Sensitive Factor.. Blood. 1466-1466. 2006
- Endogenous Arteriolar Fibrinolysis Requires Urokinase Plasminogen Activator and Leukocyte Urokinase Plasminogen Activator Receptor-1.. Blood. 545-545. 2006
- Fondiparinux Worsens Leukocyte Endothelial Interactions Improved by Antithrombin and Increases Leukocyte Extravasation.. Blood. 1646-1646. 2006
- Anticoagulant heparan sulfate mediates anti_inflammatory effects. Matrix Biology. S42-S43. 2006
- Endothelial anticoagulant heparan sulfate mediates anti-inflammatory effects of antithrombin in sepsis.. Circulation. 116-116. 2006
- A Novel Thrombin Fluorogenic Substrate of High Affinity, Catalytic Efficiency and Selectivity.. Blood. 1953-1953. 2005
- Anticoagulant Heparan Sulfate Mediates Antithrombin Amelioration of Leukocyte-Endothelial Interactions in Sepsis.. Blood. 3684-3684. 2005
- Atorvastatin Inhibits Leukocyte Firm Adhesion to Arterial Thrombi as Observed in the Mouse Cremaster Muscle.. Blood. 3821-3821. 2004
- Impaired thrombus growth and stability in vitro nectin deficient mice.. Blood. 781A-781A. 2003
- Localization of thrombin activity with self-quenching fluorogenic substrates during arterial thrombi formation in living mice.. Blood. 13A-13A. 2003
- Kinetics of platelet activation, P-selectin expression and leukocyte rolling during arterial thrombus formation in vivo.. Blood. 23A-23A. 2002
- In vivo real time imaging of arterial thrombus formation reveals P-selectin- and PSGL-1-mediated tissue factor accumulation as a mechanism for fibrin clot generation.. Blood. 823A-823A. 2001
- Glycoprotein Ib and PSGL-1 serve as platelet ligands for platelet-endothelial cell interaction during platelet rolling on stimulated postcapillary venules in vivo.. Blood. 812A-812A. 2000
- AN ENZYMATIC DIAGNOSTIC-TEST FOR HEPARIN-INDUCED THROMBOCYTOPENIA. Thrombosis and Haemostasis. 565-565. 1993
- CHRONIC ADMINISTRATION OF ETHANOL INHIBITS ENHANCED RESPONSES TO COLLAGEN OF PLATELETS FROM HYPERCHOLESTEROLEMIC RABBITS. Thrombosis and Haemostasis. 1068-1068. 1993
- ACUTE INVITRO AND CHRONIC INVIVO EFFECTS OF ETHANOL ON AGGREGATION OF PLATELETS FROM CHOLESTEROL-FED RABBITS. Thrombosis and Haemostasis. 919-919. 1991
- FUNCTIONS OF PLATELETS FROM DIET-INDUCED HYPERCHOLESTEROLEMIC AND WATANABE (WHHL) RABBITS. Arteriosclerosis. A948-A948. 1990
-
journal articles
- A sub-study of the POISE-3 randomized trial examined effects of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of acute kidney injury.. Kidney International. S0085-2538(24)00717-8. 2024
- Small Molecules Targeting GRP78 Mitigate Anti- GRP78 Autoantibody-Mediated Tissue Factor Procoagulant Activity in Cultured Endothelial Cells. Journal of Thrombosis and Haemostasis. 22:3290-3304. 2024
- Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors. Journal of Thrombosis and Haemostasis. 22:2761-2766. 2024
- A specific fluorescence resonance energy quenching–based biosensor for measuring thrombin activity in whole blood. Journal of Thrombosis and Haemostasis. 22:1627-1639. 2024
- Risk of thrombosis and bleeding in gynecologic cancer surgery: systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. 230:403-416. 2024
- Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model. Journal of Thrombosis and Haemostasis. 22:263-270. 2024
- Previous Ischemic Stroke Significantly Alters Stroke Risk in Newly Diagnosed Cancer Patients. Stroke. 54:3064-3073. 2023
- PAR4 Inhibition Reduces Coronary Artery Atherosclerosis and Myocardial Fibrosis in SR-B1/LDLR Double Knockout Mice. Arteriosclerosis, Thrombosis and Vascular Biology. 43:2165-2178. 2023
- TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol. BMJ Open. 13:e064715-e064715. 2023
- Supplemental fibrinogen restores thrombus formation in cardiopulmonary bypass-induced platelet dysfunction ex vivo. British Journal of Anaesthesia. 131:452-462. 2023
- What can ex vivo experiments contribute to clinical haemostasis management?. British Journal of Anaesthesia. 131:424-425. 2023
- Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients. JACC: CardioOncology. 5:201-202. 2023
- Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature. PLoS ONE. 18:e0293632-e0293632. 2023
- Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery. Trials. 23:101. 2022
- Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins. Nature Communications. 13:6323. 2022
- Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study. Journal of Surgical Oncology. 126:386-393. 2022
- Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative Review. Thrombosis and Haemostasis. 122:1255-1264. 2022
- Tranexamic Acid in Patients Undergoing Noncardiac Surgery. New England Journal of Medicine. 386:1986-1997. 2022
- Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury: A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical Trial. Canadian Journal of Kidney Health and Disease. 9:205435812110692-205435812110692. 2022
- Comparing Exercise-Induced Musculoskeletal Bleeding in Murine Models of Hemophilia A and B. Blood. 138:1031-1031. 2021
- ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery. European Urology Focus. 7:1222-1225. 2021
- A long-half-life, high-affinity P-selectin inhibitor. Blood. 138:1096-1097. 2021
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. New England Journal of Medicine. 385:777-789. 2021
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. New England Journal of Medicine. 385:790-802. 2021
- Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study. Journal of Thrombosis and Haemostasis. 19:1546-1557. 2021
- Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thrombosis Research. 202:176-181. 2021
- Multimerin 1 supports platelet function in vivo and binds to specific GPAGPOGPX motifs in fibrillar collagens that enhance platelet adhesion. Journal of Thrombosis and Haemostasis. 19:547-561. 2021
- Professor Marian A. Packham, CM, PhD, DSc, FRSC (1927–2020). Journal of Thrombosis and Haemostasis. 19:311-312. 2021
- Tranexamic acid and rosuvastatin in patients at risk of cardiovascular events after noncardiac surgery: a pilot of the POISE-3 randomized controlled trial. Pilot and Feasibility Studies. 6:104. 2020
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clinical Trials. 17:491-500. 2020
- Activated thrombin‐activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin‐dependent plasmin generation on thrombin‐activated platelets. Journal of Thrombosis and Haemostasis. 18:2364-2376. 2020
- Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease. Arteriosclerosis, Thrombosis and Vascular Biology. 40:1958-1960. 2020
- Extended thromboprophylaxis following colorectal surgery in patients with inflammatory bowel disease: a comprehensive systematic clinical review. Colorectal Disease. 22:663-678. 2020
- Thrombin generation and bleeding in cardiac surgery: a clinical narrative review. Canadian Journal of Anaesthesia. 67:746-753. 2020
- Thromboembolism in Older Adults. Frontiers in Medicine. 7:470016. 2020
- Thrombus stability explains the factor V Leiden paradox: a mouse model. Blood Advances. 3:3375-3378. 2019
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Internal Medicine. 179:1469-1469. 2019
- An assay to measure levels of factor Xa inhibitors in blood and plasma. Journal of Thrombosis and Haemostasis. 17:1153-1159. 2019
- Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi. Thrombosis and Haemostasis. 119:992-999. 2019
- Canadian Urological Association guideline on perioperative thromboprophylaxis and management of anticoagulation. Journal of the Canadian Urological Association. 13:105-114. 2019
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. New England Journal of Medicine. 380:711-719. 2019
- Identification and characterization of a factor Va-binding site on human prothrombin fragment 2. Scientific Reports. 9:2436. 2019
- Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation. Canadian Journal of Cardiology. 35:160-168. 2019
- Erratum to: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study. Thrombosis and Haemostasis. 118:2188-2188. 2018
- Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model. Arteriosclerosis, Thrombosis and Vascular Biology. 38:2338-2344. 2018
- Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale. Thrombosis and Haemostasis. 118:1679-1680. 2018
- Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study. Thrombosis and Haemostasis. 118:842-851. 2018
- Addressing the burden of hospital‐related venous thromboembolism: the role of extended anticoagulant prophylaxis. Journal of Thrombosis and Haemostasis. 16:413-417. 2018
- Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study. Thrombosis Research. 163:41-46. 2018
- Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. New England Journal of Medicine. 378:699-707. 2018
- Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering. Arteriosclerosis, Thrombosis and Vascular Biology. 38:26-39. 2018
- HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis. Matrix Biology. 63:69-90. 2017
- Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation. American Journal of Cardiology. 120:582-587. 2017
- Soluble P-selectin is the smoke, not the fire. Blood. 130:101-102. 2017
- Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study. Thrombosis Research. 152:44-48. 2017
- Emerging anticoagulant strategies. Blood. 129:147-154. 2017
- Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins. Frontiers in Medicine. 4:142. 2017
- The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thrombosis and Haemostasis. 117:2415-2424. 2017
- Animal Models of Thrombosis From Zebrafish to Nonhuman Primates. Circulation Research. 118:1363-1379. 2016
- Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation. American Journal of Cardiology. 117:1107-1111. 2016
- Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study. Journal of Thrombosis and Haemostasis. 14:504-509. 2016
- Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism. Journal of Thrombosis and Haemostasis. 14:143-152. 2016
- Delayed but not Early Treatment with DNase Reduces Organ Damage and Improves Outcome in a Murine Model of Sepsis. Shock. 44:166-172. 2015
- Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein. Blood. 125:2712-2719. 2015
- Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit). American Journal of Cardiology. 115:641-646. 2015
- Clinical Challenges in Patients with Cancer-Associated Thrombosis: Canadian Expert Consensus Recommendations. Current Oncology. 22:49-59. 2015
-
d -Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy. ACP journal club. 162:27-34. 2015 - Effect of ascorbate on fibrinolytic factors in septic mouse skeletal muscle. Blood Coagulation and Fibrinolysis. 25:745-753. 2014
- Plasma fibronectin supports hemostasis and regulates thrombosis. Journal of Clinical Investigation. 124:4281-4293. 2014
- Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood. 124:1020-1028. 2014
- Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models. Thrombosis and Haemostasis. 112:412-418. 2014
- Abnormal megakaryocyte development and platelet function in Nbeal2−/− mice. Blood. 122:3349-3358. 2013
- Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty. ACP journal club. 158:800-800. 2013
-
Selective
d -Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis. ACP journal club. 158:93-93. 2013 - Atorvastatin Delays Murine Platelet Activation In Vivo Even in the Absence of Endothelial NO Synthase. Arteriosclerosis, Thrombosis and Vascular Biology. 32:2609-2615. 2012
- Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet‐mediated events during thrombus formation. Journal of Thrombosis and Haemostasis. 10:1109-1119. 2012
- Cardiovascular Devices and Platelet Interactions. Circulation: Cardiovascular Interventions. 5:296-304. 2012
- Exploring the Impact of Clinical Anticoagulants on Venous Thrombosis Stability Using a Novel Intravital Murine Model. Blood. 118:1246-1246. 2011
- The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. Journal of Clinical Investigation. 121:4537-4547. 2011
- Salivary microvesicles clot blood. Blood. 117:2989-2989. 2011
- BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase. Thrombosis and Haemostasis. 106:1203-1214. 2011
- Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries. Intensive Care Medicine. 36:1928-1934. 2010
- Tissue Factor and Thrombosis Models. Arteriosclerosis, Thrombosis and Vascular Biology. 30:900-908. 2010
- Tissue factor microparticles and haemophilia. Thrombosis Research. 125:S67-S69. 2010
- Abnormal hemostasis in a knock‐in mouse carrying a variant of factor IX with impaired binding to collagen type IV. Journal of Thrombosis and Haemostasis. 7:1843-1851. 2009
- New Antithrombotic Drugs. Clinical Pharmacology and Therapeutics. 86:139-146. 2009
- Preface. Journal of Thrombosis and Haemostasis. 7:1-1. 2009
- Inferior Vena Cava Ligation Rapidly Induces Tissue Factor Expression and Venous Thrombosis in Rats. Arteriosclerosis, Thrombosis and Vascular Biology. 29:863-869. 2009
- Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor. Blood. 113:1809-1817. 2009
- Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis. Thrombosis and Haemostasis. 102:1212-1218. 2009
- Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia. Cardiovascular Pathology. 17:226-232. 2008
- New Anticoagulants for Treatment of Venous Thromboembolism. Arteriosclerosis, Thrombosis and Vascular Biology. 28:380-386. 2008
- Platelet PECAM-1 inhibits thrombus formation in vivo. Blood. 107:535-541. 2006
- Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. Journal of Leukocyte Biology. 78:1318-1326. 2005
- In Vivo Models of Platelet Function and Thrombosis: Study of Real-Time Thrombus Formation. Methods in molecular biology (Clifton, N.J.). 272:187-198. 2004
- Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin. Journal of Experimental Medicine (JEM). 197:1585-1598. 2003
- Thrombus formation: direct real-time observation and digital analysis of thrombus assembly in a living mouse by confocal and widefield intravital microscopy. Journal of Thrombosis and Haemostasis. 1:60-68. 2003
- Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nature Medicine. 8:1175-1180. 2002
- The Endothelium and Thrombosis. Seminars in Thrombosis and Hemostasis. 26:463-478. 2000
- Enhanced collagen-induced responses of platelets from rabbits with diet-induced hypercholesterolemia are due to increased sensitivity to TxA2. Response inhibition by chronic ethanol administration in hypercholesterolemia is due to reduced TxA2 formation.. Arteriosclerosis, Thrombosis and Vascular Biology. 14:1379-1385. 1994
- Acute in vitro effects of ethanol on responses of platelets from cholesterol-fed and Watanabe heritable hyperlipidemic rabbits.. Arteriosclerosis, Thrombosis and Vascular Biology. 12:437-445. 1992
- In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.. Thrombosis and Haemostasis. 61:254-258. 1989
- In Vitro Effects of Ethanol on Rabbit Platelet Aggregation, Secretion of Granule Contents, and Cyclic AMP Levels in the Presence of Prostacyclin. Thrombosis and Haemostasis. 61:254-258. 1989
- Malignant Lymphoma Presenting as Kaposi's Sarcoma in a Homosexual Man with the Acquired Immunodeficiency Syndrome. ACP journal club. 102:338-338. 1985